Clinical trial
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill…
NCT00077753 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00077753 |
|---|---|
| Title | EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization |
| Official title | A Double-Blind, Placebo-Controlled, Parallel, Multicenter Study on Extended VTE Prophylaxis in Acutely Ill Medical Patients With Prolonged Immobilization |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | enoxaparin sodium |
| Enrollment | 4,726 |
| Start date | Feb 1, 2002 |
| Primary completion | Oct 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Feb 16, 2004 |
| Last update posted | Jan 11, 2011 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, France, Germany, India, Israel, Italy and 8 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: